First Hepatitis C Settlements Reached In Japan Prefectures
This article was originally published in PharmAsia News
Executive Summary
The first cases of hepatitis C suits filed against the government have been settled in Japan's prefectures of Fukuoka and Osaka, with 29 plaintiffs agreeing to government-proposed compensation. Damage suits filed against drug makers such as Mitsubishi Tanabe Pharma for selling tainted blood that caused fatal liver ailments in Japanese patients remain in play. Negotiations by the 29, who were among about 240 people to file suit as far back as 2002, are not expected to be held with the drug makers. The government also is considering plans to offer help for hepatitis B and C patients not covered by a law passed last month to enable the settlements. (Click here for more
You may also be interested in...
Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD
A National Advertising Division review of claims by LVMH-owned Fenty Skin determined makeup- and dirt-removal representations were substantiated by a study and subject questionnaire, but demo videos from paid endorsers must include disclosures about material connections in accordance with FTC guidelines.
Clinical Trial Diversity Requires Sponsors Work With An Assortment Of Patient Advocates, Community Organizations
US FDA oncology officials are concerned that the entities sponsors are consulting in developing and implementing clinical trial diversity plans are not sufficiently diverse themselves and do not represent patients in underserved communities.
Israeli Company Lands De Novo Clearance For Digital Bone Marrow Application
The US FDA has cleared a novel software application to enhance the analysis of bone marrow smears. Using the AI-powered tool, hematopathologists may be able to better diagnose various blood and marrow diseases.